News for AcelRx Pharmaceuticals Inc - Google Finance

ACELRX PHARMACEUTICALS INC. : Top-line Data Demonstrate Primary ...

Tue, 21 May 2013 11:50:55 GMT

ACELRX PHARMACEUTICALS INC. : Top-line Data Demonstrate Primary ...
4-traders (press release) - May 21, 2013

REDWOOD CITY, Calif., May 21, 2013/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...

Top After-Market NASDAQ Movers (FX Energy, NetApp, Canadian Solar ...

Wed, 22 May 2013 06:53:41 GMT

Top After-Market NASDAQ Movers (FX Energy, NetApp, Canadian Solar ...
International Business Times - May 22, 2013

The top stocks to gain during after-market hours on the Nasdaq on Tuesday were FX Energy Inc, NetApp Inc, Canadian Solar Inc, DryShips Inc, and AcelRx Pharmaceuticals Inc. The top after-market losers on the Nasdaq were AMAG Pharmaceuticals Inc, ...

AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) reaches primary end point on ...

Thu, 23 May 2013 12:52:16 GMT

AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) reaches primary end point on ...
WallStreetPR - 9 hours ago

Boston, MA 05/23/2013 (wallstreetpr) - The share prices of AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) surged by 13.44 percent to close at $7.26 per share for the end of last trading session.

AcelRX post-op pain treatment meets late-stage study goal

Tue, 21 May 2013 12:16:51 GMT

AcelRX post-op pain treatment meets late-stage study goal
Reuters - May 21, 2013

(Reuters) - AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent.

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), NPS Pharmaceuticals, Inc ...

Wed, 22 May 2013 12:41:06 GMT

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), NPS Pharmaceuticals, Inc ...
SBWire (press release) - May 22, 2013

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) a development stage specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain closed down in its previous session ...

ACELRX PHARMACEUTICALS INC : AcelRx Pharmaceuticals to Present at the ...

Thu, 16 May 2013 19:26:20 GMT

ACELRX PHARMACEUTICALS INC : AcelRx Pharmaceuticals to Present at the ...
4-traders (press release) - May 16, 2013

REDWOOD CITY, Calif., May 16, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...

Stocks To Watch: ReneSola Ltd. (ADR), SemiLEDs Corporation, Trina Solar ...

Tue, 21 May 2013 15:13:50 GMT

Stocks To Watch: ReneSola Ltd. (ADR), SemiLEDs Corporation, Trina Solar ...
Openglobe - May 21, 2013

ReneSola Ltd. (ADR) (NYSE:SOL) shares increased 4.86% to $2.59. The company, on May 10, announced it provided modules for use in three community-scale solar power projects in Vermont in the last few months.

AcelRx Pharmaceuticals Q1 13 Earnings Conference Call At 4:30 PM ET

Wed, 08 May 2013 19:03:52 GMT

AcelRx Pharmaceuticals Q1 13 Earnings Conference Call At 4:30 PM ET
NASDAQ - May 8, 2013

(RTTNews.com) - AcelRx Pharmaceuticals Inc.( ACRX ) will host a conference call at 4:30 PM ETMay 8, 2013, to discuss its Q1 13 earnings results.

ACELRX PHARMACEUTICALS INC : Top-line Data Show AcelRx ...

Wed, 24 Apr 2013 11:37:11 GMT

ACELRX PHARMACEUTICALS INC : Top-line Data Show AcelRx ...
4-traders (press release) - Apr 24, 2013

REDWOOD CITY, Calif., April 24, 2013 /PRNewswire/ --- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...

Higher dose of AcelRx pain drug meets trial goal - Yahoo! News

AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results

Wed, 08 May 2013 20:07:14 GMT

AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
PR Newswire (press release) - May 8, 2013

REDWOOD CITY, Calif., May 8, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...

AcelRx Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call ... - Seeking Alpha